Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - CASH & EQUIVALENTS
Cash & Equivalents NVAX - Novavax, Inc.
569 M
LAST VALUE
-38.74%
2 YEAR CAGR
51.96%
5 YEAR CAGR
16.88%
10 YEAR CAGR